DLL3 and small cell lung carcinoma: Delta-like ligand 3 (DLL3), an inhibitory ligand of the NOTCH pathway, exhibits aberrant expression on the cell surface of approximately 85% of SCLC cells while showing minimal expression in normal tissues [43,44].